Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sukmook Lee

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Biomolecules|March 7, 2020
TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody TherapyKyun Heo, Sukmook Lee
Cells|April 3, 2021
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer TherapyJi Woong Kim, Yea Bin Cho, Sukmook Lee
Cells|June 2, 2021
Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. <i>Cells</i> 2021, <i>10</i>, 670Ji Woong Kim, Yea Bin Cho, Sukmook Lee
Journal of Immunological Methods|June 12, 2016
Development of a sandwich enzyme-linked immunosorbent assay for the detection of CD44v3 using exon v3- and v6-specific monoclonal antibody pairsMee Hyun Jeoung, Taek-Keun Kim, Hyunbo Shim, et al.
Biomedicines|January 20, 2021
Recent Advances in Monoclonal Antibody Therapy for Colorectal CancersKyusang Hwang, Jin Hwan Yoon, Ji Hyun Lee, et al.
Molecular Aspects of Medicine|December 15, 2025
Targeting emerging viruses with phage display-driven engineered antibodies: Bridging molecular design and clinical applicationAh Hyun Cho, Su Yeon Cho, Soohyun Kim, et al.
International Journal of Biological Macromolecules|January 4, 2026
Bridging discovery and therapy in precision medicine-Phage display as a catalyst for nanobody innovation: A reviewHee Eon Lee, Jae Hyeon Hwang, Michael Lim, et al.
International Journal of Molecular Sciences|May 28, 2022
Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer ImmunotherapyHa Gyeong Shin, Ha Rim Yang, Aerin Yoon, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 20, 2011
Aurintricarboxylic acid inhibits the nuclear factor-κB-dependent expression of intercellular cell adhesion molecule-1 and endothelial cell selectin on activated human endothelial cellsJi-Eun Kim, Sukmook Lee, Kyou-Sup Han, et al.
International Journal of Biological Macromolecules|July 10, 2025
Development of a novel CD3ε-specific human antibody for selective modulation of T cell activationHa Rim Yang, Ji Woong Kim, Hye Lim Choi, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Biomolecules|March 7, 2020
TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody TherapyKyun Heo, Sukmook Lee
Cells|April 3, 2021
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer TherapyJi Woong Kim, Yea Bin Cho, Sukmook Lee
Cells|June 2, 2021
Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. <i>Cells</i> 2021, <i>10</i>, 670Ji Woong Kim, Yea Bin Cho, Sukmook Lee
Journal of Immunological Methods|June 12, 2016
Development of a sandwich enzyme-linked immunosorbent assay for the detection of CD44v3 using exon v3- and v6-specific monoclonal antibody pairsMee Hyun Jeoung, Taek-Keun Kim, Hyunbo Shim, et al.
Biomedicines|January 20, 2021
Recent Advances in Monoclonal Antibody Therapy for Colorectal CancersKyusang Hwang, Jin Hwan Yoon, Ji Hyun Lee, et al.
Molecular Aspects of Medicine|December 15, 2025
Targeting emerging viruses with phage display-driven engineered antibodies: Bridging molecular design and clinical applicationAh Hyun Cho, Su Yeon Cho, Soohyun Kim, et al.
International Journal of Biological Macromolecules|January 4, 2026
Bridging discovery and therapy in precision medicine-Phage display as a catalyst for nanobody innovation: A reviewHee Eon Lee, Jae Hyeon Hwang, Michael Lim, et al.
International Journal of Molecular Sciences|May 28, 2022
Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer ImmunotherapyHa Gyeong Shin, Ha Rim Yang, Aerin Yoon, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 20, 2011
Aurintricarboxylic acid inhibits the nuclear factor-κB-dependent expression of intercellular cell adhesion molecule-1 and endothelial cell selectin on activated human endothelial cellsJi-Eun Kim, Sukmook Lee, Kyou-Sup Han, et al.
International Journal of Biological Macromolecules|July 10, 2025
Development of a novel CD3ε-specific human antibody for selective modulation of T cell activationHa Rim Yang, Ji Woong Kim, Hye Lim Choi, et al.
Pageof 7